BUSINESS
By EILEEN AMBROSE | July 27, 2008
Women worry more about retirement than men. We fret more about inflation eroding our purchasing power. We agonize more over declining health and the rising cost of medical care. We stew more about outliving our money. In fact, according to a recent survey by The Hartford and MIT AgeLab, there's only one retirement issue where men's anxiety level was higher: Men are more concerned about being bored in retirement. But we have good reason to worry. Women tend to earn less than men and are more likely to quit work to care for children or elderly parents.
NEWS
July 24, 2007
As with most of Washington's titanic battles, many of the casualties from the immigration debacle were unintended victims. Among those with the poor luck to be in the line of fire were Maryland's shrinking crab-processing industry and the mostly Mexican women who make up its seasonal work force. Congress should remedy this injustice as soon as possible by establishing a permanent program that allows such workers visas to come for a few months each year and then go home, without making them and their employers sweat through the 11th-hour theatrics of annual renewals.
NEWS
By Stephen Smith and Stephen Smith,New York Times News Service | April 6, 2007
A 2002 study that led millions of women to throw out their hormone pills may have overestimated the dangers of that medication to women in their 50s, new research suggests. The new study in Wednesday's Journal of the American Medical Association found that for women near the start of menopause, the pills do not increase the incidence of heart attacks or other cardiac complications. Findings regarding stroke were less clear cut, but researchers said that the youngest women appeared to be at the lowest risk.
NEWS
By LOS ANGELES TIMES | June 23, 2004
Estrogen therapy not only does not protect women age 65 and older against Alzheimer's disease or other forms of dementia, as scientists once hoped, but it might slightly hasten senility, according to the results of a study of women's health. These results, reported today in the Journal of the American Medical Association, could end scientists' hopes for estrogen replacement therapy in older women. The treatment, once thought to reduce many of the ravages of age, such as strokes and dementia, seems to enhance those problems.
NEWS
By Roni Rabin and Roni Rabin,NEWSDAY | April 21, 2004
Just weeks after the National Institutes of Health halted a large study, finding that estrogen's risks outweighed benefits for post-menopausal women, a privately funded trial will look at whether hormone therapy prevents hardening of the arteries in younger women, ages 40-55. The private Kronos Longevity Research Institute, based in Phoenix, Ariz., selected eight research centers at some of the most prestigious medical schools - including Columbia, Harvard and Yale - to participate in the $12 million study.
NEWS
By Ellen Goodman | April 13, 1999
BOSTON -- The heart of the story is the tape measure. Try to imagine the best and the brightest female tenured professors lurking around the halls of the Massachusetts Institute of Technology, measuring the size of the men's labs and offices against their own.There is something so techie about it, so wonky, so MIT. The 15 women -- physicists, chemists, biologists -- were in search of hard numbers to prove what they had once been reluctant to admit: Men...